- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/32 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
Patent holdings for IPC class C07C 323/32
Total number of patents in this class: 84
10-year publication summary
|
3
|
6
|
7
|
5
|
3
|
2
|
8
|
8
|
6
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cybin IRL Limited | 71 |
9 |
| Acucela Inc. | 153 |
7 |
| Enzo Therapeutics, Inc. | 28 |
7 |
| Virginia Commonwealth University | 665 |
5 |
| KYORIN Pharmaceutical Co., Ltd. | 157 |
3 |
| Sunovion Pharmaceuticals Inc. | 244 |
3 |
| Roche Diagnostics Operations, Inc. | 1522 |
2 |
| 3m Innovative Properties Company | 17458 |
2 |
| Centre National de La Recherche Scientifique | 11059 |
2 |
| Adeka Corporation | 1380 |
2 |
| DNP Fine Chemicals Co., Ltd. | 184 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 398 |
2 |
| Reviva Pharmaceuticals, Inc. | 50 |
2 |
| Gilgamesh Pharmaceuticals, Inc. | 64 |
2 |
| Catena Biosciences, Inc. | 5 |
2 |
| Bristol-myers Squibb Company | 4757 |
1 |
| F. Hoffmann-La Roche AG | 7808 |
1 |
| Hoffmann-La Roche Inc. | 3818 |
1 |
| Pfizer Inc. | 3409 |
1 |
| Syngenta Crop Protection AG | 6730 |
1 |
| Other owners | 27 |